Peri-Implantitis Market By Treatment Type (Non-Surgical Treatments {Mechanical Debridement, Antiseptics, Antibiotic Therapy, Laser Therapy}, Surgical Treatments {Flap Surgery, Bone Grafting, Soft Tissue Augmentation, Implantoplasty}, Adjunctive Therapies), By Product (Implant Cleaning Devices {Ultrasonic Scalers, Air-polishing Devices}, Local Drug Delivery Products, Regenerative Products, Laser Systems, Therapeutic Agents), By Material Type (Implant Materials {Titanium Implants, Zirconia Implants}, Graft Materials {Autografts, Allografts, Xenografts, Synthetic Bone Grafts}), By End-user (Dental Clinics, Hospitals, Specialty Clinics, Academic and Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Peri-Implantitis Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. The increasing adoption of dental implants is due to growing awareness and aesthetic demands.

3.2.2. The global rise in aging populations increases susceptibility to dental issues, fueling market growth.

3.2.3. Innovative diagnostic tools and treatment technologies boost the detection and management of peri-implantitis.

3.3. Key industry pitfalls & challenges

3.3.1. The cost of peri-implantitis management is a barrier for patients in low-income groups.

3.3.2. Limited awareness about peri-implantitis and its complications hampers market penetration.

3.3.3. Difficulty differentiating peri-implantitis from other periodontal diseases affects timely treatment.

3.4. Market Opportunities

3.4.1. Untapped potential in developing regions with increasing dental care infrastructure.

3.4.2. Use of AI and machine learning for early detection and personalized treatment plans.

3.4.3. Growing research into advanced therapeutic options, including biomaterials and regenerative treatments.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Peri-Implantitis Market, Treatment Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Treatment Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Non-Surgical Treatments

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.1.1. Mechanical Debridement

4.2.1.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.1.2. Antiseptics

4.2.1.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.1.3. Antibiotic Therapy

4.2.1.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.1.4. Laser Therapy

4.2.1.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Surgical Treatments

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.1.1. Flap Surgery

4.3.1.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.1.2. Bone Grafting

4.3.1.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.1.3. Soft Tissue Augmentation

4.3.1.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.1.4. Implantoplasty

4.3.1.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Adjunctive Therapies

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Peri-Implantitis Market, Product Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Product, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Implant Cleaning Devices

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.1.1. Ultrasonic Scalers

5.2.1.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.1.2. Air-polishing Devices

5.2.1.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Local Drug Delivery Products

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Regenerative Products

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Laser Systems

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Therapeutic Agents

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Peri-Implantitis Market, Material Type Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Material Type, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Implant Materials

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.2.1.1. Titanium Implants

6.2.1.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.2.1.2. Zirconia Implants

6.2.1.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Graft Materials

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3.1.1. Autografts

6.3.1.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3.1.2. Allografts

6.3.1.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3.1.3. Xenografts

6.3.1.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3.1.4. Synthetic Bone Grafts

6.3.1.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Peri-Implantitis Market, End-user Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By End-user, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Dental Clinics

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Hospitals

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Specialty Clinics

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Academic and Research Institutes

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Peri-Implantitis Market, Region Segment Analysis

8.1. Overview

8.1.1. Global Market Revenue Share, By Region, 2025 & 2035

8.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)

8.2. North America

8.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)

8.2.2. North America Market Revenue, By Treatment Type, 2025-2035

8.2.3. North America Market Revenue, By Product, 2025-2035

8.2.4. North America Market Revenue, By Material Type, 2025-2035

8.2.5. North America Market Revenue, By End-user, 2025-2035

8.2.6. The U.S.

8.2.6.1. U.S. Market Revenue, By Treatment Type, 2025-2035

8.2.6.2. U.S. Market Revenue, By Product, 2025-2035

8.2.6.3. U.S. Market Revenue, By Material Type, 2025-2035

8.2.6.4. U.S. Market Revenue, By End-user, 2025-2035

8.2.7. Canada

8.2.7.1. Canada Market Revenue, By Treatment Type, 2025-2035

8.2.7.2. Canada Market Revenue, By Product, 2025-2035

8.2.7.3. Canada Market Revenue, By Material Type, 2025-2035

8.2.7.4. Canada Market Revenue, By End-user, 2025-2035

8.3. Europe

8.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)

8.3.2. Europe Market Revenue, By Treatment Type, 2025-2035

8.3.3. Europe Market Revenue, By Product, 2025-2035

8.3.4. Europe Market Revenue, By Material Type, 2025-2035

8.3.5. Europe Market Revenue, By End-user, 2025-2035

8.3.6. Germany

8.3.6.1. Germany Market Revenue, By Treatment Type, 2025-2035

8.3.6.2. Germany Market Revenue, By Product, 2025-2035

8.3.6.3. Germany Market Revenue, By Material Type, 2025-2035

8.3.6.4. Germany Market Revenue, By End-user, 2025-2035

8.3.7. France

8.3.7.1. France Market Revenue, By Treatment Type, 2025-2035

8.3.7.2. France Market Revenue, By Product, 2025-2035

8.3.7.3. France Market Revenue, By Material Type, 2025-2035

8.3.7.4. France Market Revenue, By End-user, 2025-2035

8.3.8. U.K.

8.3.8.1. U.K. Market Revenue, By Treatment Type, 2025-2035

8.3.8.2. U.K. Market Revenue, By Product, 2025-2035

8.3.8.3. U.K. Market Revenue, By Material Type, 2025-2035

8.3.8.4. U.K. Market Revenue, By End-user, 2025-2035

8.3.9. Italy

8.3.9.1. Italy Market Revenue, By Treatment Type, 2025-2035

8.3.9.2. Italy Market Revenue, By Product, 2025-2035

8.3.9.3. Italy Market Revenue, By Material Type, 2025-2035

8.3.9.4. Italy Market Revenue, By End-user, 2025-2035

8.3.10. Spain

8.3.10.1. Spain Market Revenue, By Treatment Type, 2025-2035

8.3.10.2. Spain Market Revenue, By Product, 2025-2035

8.3.10.3. Spain Market Revenue, By Material Type, 2025-2035

8.3.10.4. Spain Market Revenue, By End-user, 2025-2035

8.3.11. Rest of Europe

8.3.11.1. Rest of Europe Market Revenue, By Treatment Type, 2025-2035

8.3.11.2. Rest of Europe Market Revenue, By Product, 2025-2035

8.3.11.3. Rest of Europe Market Revenue, By Material Type, 2025-2035

8.3.11.4. Rest of Europe Market Revenue, By End-user, 2025-2035

8.4. Asia Pacific

8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)

8.4.2. Asia Pacific Market Revenue, By Treatment Type, 2025-2035

8.4.3. Asia Pacific Market Revenue, By Product, 2025-2035

8.4.4. Asia Pacific Market Revenue, By Material Type, 2025-2035

8.4.5. Asia Pacific Market Revenue, By End-user, 2025-2035

8.4.6. China

8.4.6.1. China Market Revenue, By Treatment Type, 2025-2035

8.4.6.2. China Market Revenue, By Product, 2025-2035

8.4.6.3. China Market Revenue, By Material Type, 2025-2035

8.4.6.4. China Market Revenue, By End-user, 2025-2035

8.4.7. Japan

8.4.7.1. Japan Market Revenue, By Treatment Type, 2025-2035

8.4.7.2. Japan Market Revenue, By Product, 2025-2035

8.4.7.3. Japan Market Revenue, By Material Type, 2025-2035

8.4.7.4. Japan Market Revenue, By End-user, 2025-2035

8.4.8. India

8.4.8.1. India Market Revenue, By Treatment Type, 2025-2035

8.4.8.2. India Market Revenue, By Product, 2025-2035

8.4.8.3. India Market Revenue, By Material Type, 2025-2035

8.4.8.4. India Market Revenue, By End-user, 2025-2035

8.4.9. Australia

8.4.9.1. Australia Market Revenue, By Treatment Type, 2025-2035

8.4.9.2. Australia Market Revenue, By Product, 2025-2035

8.4.9.3. Australia Market Revenue, By Material Type, 2025-2035

8.4.9.4. Australia Market Revenue, By End-user, 2025-2035

8.4.10. South Korea

8.4.10.1. South Korea Market Revenue, By Treatment Type, 2025-2035

8.4.10.2. South Korea Market Revenue, By Product, 2025-2035

8.4.10.3. South Korea Market Revenue, By Material Type, 2025-2035

8.4.10.4. South Korea Market Revenue, By End-user, 2025-2035

8.4.11. Singapore

8.4.11.1. Singapore Market Revenue, By Treatment Type, 2025-2035

8.4.11.2. Singapore Market Revenue, By Product, 2025-2035

8.4.11.3. Singapore Market Revenue, By Material Type, 2025-2035

8.4.11.4. Singapore Market Revenue, By End-user, 2025-2035

8.4.12. Rest of Asia Pacific

8.4.12.1. Rest of Asia Pacific Market Revenue, By Treatment Type, 2025-2035

8.4.12.2. Rest of Asia Pacific Market Revenue, By Product, 2025-2035

8.4.12.3. Rest of Asia Pacific Market Revenue, By Material Type, 2025-2035

8.4.12.4. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

8.5. Latin America

8.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)

8.5.2. Latin America Market Revenue, By Treatment Type, 2025-2035

8.5.3. Latin America Market Revenue, By Product, 2025-2035

8.5.4. Latin America Market Revenue, By Material Type, 2025-2035

8.5.5. Latin America Market Revenue, By End-user, 2025-2035

8.5.6. Brazil

8.5.6.1. Brazil Market Revenue, By Treatment Type, 2025-2035

8.5.6.2. Brazil Market Revenue, By Product, 2025-2035

8.5.6.3. Brazil Market Revenue, By Material Type, 2025-2035

8.5.6.4. Brazil Market Revenue, By End-user, 2025-2035

8.5.7. Argentina

8.5.7.1. ArgentinaMarket Revenue, By Treatment Type, 2025-2035

8.5.7.2. Argentina Market Revenue, By Product, 2025-2035

8.5.7.3. Argentina Market Revenue, By Material Type, 2025-2035

8.5.7.4. Argentina Market Revenue, By End-user, 2025-2035

8.5.8. Mexico

8.5.8.1. Mexico Market Revenue, By Treatment Type, 2025-2035

8.5.8.2. Mexico Market Revenue, By Product, 2025-2035

8.5.8.3. Mexico Market Revenue, By Material Type, 2025-2035

8.5.8.4. Mexico Market Revenue, By End-user, 2025-2035

8.5.9. Rest of Latin America

8.5.9.1. Rest of Latin America Market Revenue, By Treatment Type, 2025-2035

8.5.9.2. Rest of Latin America Market Revenue, By Product, 2025-2035

8.5.9.3. Rest of Latin America Market Revenue, By Material Type, 2025-2035

8.5.9.4. Rest of Latin America Market Revenue, By End-user, 2025-2035

8.6. MEA

8.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)

8.6.2. MEA Market Revenue, By Treatment Type, 2025-2035

8.6.3. MEA Market Revenue, By Product, 2025-2035

8.6.4. MEA Market Revenue, By Material Type, 2025-2035

8.6.5. MEA Market Revenue, By End-user, 2025-2035

8.6.6. GCC Countries

8.6.6.1. GCC Countries Market Revenue, By Treatment Type, 2025-2035

8.6.6.2. GCC Countries Market Revenue, By Product, 2025-2035

8.6.6.3. GCC Countries Market Revenue, By Material Type, 2025-2035

8.6.6.4. GCC Countries Market Revenue, By End-user, 2025-2035

8.6.7. South Africa

8.6.7.1. South Africa Market Revenue, By Treatment Type, 2025-2035

8.6.7.2. South Africa Market Revenue, By Product, 2025-2035

8.6.7.3. South Africa Market Revenue, By Material Type, 2025-2035

8.6.7.4. South Africa Market Revenue, By End-user, 2025-2035

8.6.8. Rest of Middle-East & Africa

8.6.8.1. Rest of Middle-East & Africa Market Revenue, By Treatment Type, 2025-2035

8.6.8.2. Rest of Middle-East & Africa Market Revenue, By Product, 2025-2035

8.6.8.3. Rest of Middle-East & Africa Market Revenue, By Material Type, 2025-2035

8.6.8.4. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

9. Company Profile

9.1. Pfizer Inc.

9.1.1. Business Overview

9.1.2. Financial Performance

9.1.3. Treatment/Service Offerings

9.1.4. Strategies & recent developments

9.1.5. SWOT Analysis

9.2. Cadila Pharmaceuticals

9.2.1. Business Overview

9.2.2. Financial Performance

9.2.3. Treatment/Service Offerings

9.2.4. Strategies & recent developments

9.2.5. SWOT Analysis

9.3. R.N. Laboratories Pvt. Ltd.

9.3.1. Business Overview

9.3.2. Financial Performance

9.3.3. Treatment/Service Offerings

9.3.4. Strategies & recent developments

9.3.5. SWOT Analysis

9.4. Basic Pharma Life Science Pvt. Ltd.

9.4.1. Business Overview

9.4.2. Financial Performance

9.4.3. Treatment/Service Offerings

9.4.4. Strategies & recent developments

9.4.5. SWOT Analysis

9.5. Prachi Pharmaceuticals Private Limited

9.5.1. Business Overview

9.5.2. Financial Performance

9.5.3. Treatment/Service Offerings

9.5.4. Strategies & recent developments

9.5.5. SWOT Analysis

9.6. Geistlich Pharma Inc.

9.6.1. Business Overview

9.6.2. Financial Performance

9.6.3. Treatment/Service Offerings

9.6.4. Strategies & recent developments

9.6.5. SWOT Analysis

9.7. Healthy Life Pharma Private Limited

9.7.1. Business Overview

9.7.2. Financial Performance

9.7.3. Treatment/Service Offerings

9.7.4. Strategies & recent developments

9.7.5. SWOT Analysis

9.8. Straumann AG

9.8.1. Business Overview

9.8.2. Financial Performance

9.8.3. Treatment/Service Offerings

9.8.4. Strategies & recent developments

9.8.5. SWOT Analysis

9.9. Dentsply Sirona

9.9.1. Business Overview

9.9.2. Financial Performance

9.9.3. Treatment/Service Offerings

9.9.4. Strategies & recent developments

9.9.5. SWOT Analysis

9.10. Zimmer Biomet

9.10.1. Business Overview

9.10.2. Financial Performance

9.10.3. Treatment/Service Offerings

9.10.4. Strategies & recent developments

9.10.5. SWOT Analysis

9.11. Nobel Biocare

9.11.1. Business Overview

9.11.2. Financial Performance

9.11.3. Treatment/Service Offerings

9.11.4. Strategies & recent developments

9.11.5. SWOT Analysis

9.12. BioHorizons

9.12.1. Business Overview

9.12.2. Financial Performance

9.12.3. Treatment/Service Offerings

9.12.4. Strategies & recent developments

9.12.5. SWOT Analysis

9.13. Osstem Implant

9.13.1. Business Overview

9.13.2. Financial Performance

9.13.3. Treatment/Service Offerings

9.13.4. Strategies & recent developments

9.13.5. SWOT Analysis

9.14. Keystone Dental

9.14.1. Business Overview

9.14.2. Financial Performance

9.14.3. Treatment/Service Offerings

9.14.4. Strategies & recent developments

9.14.5. SWOT Analysis

9.15. Neoss Limited

9.15.1. Business Overview

9.15.2. Financial Performance

9.15.3. Treatment/Service Offerings

9.15.4. Strategies & recent developments

9.15.5. SWOT Analysis